Proteome Sciences Share Discussion Threads

[peverill] 26/7/2024 12:44

Mariola in the job a few years now and done SFA for shareholders.infact the company going 30 years and done SFA for shareholders,killed a few off,aged many,while directors have done very well out of it.

[sandcrab2] 22/7/2024 12:27

The excellent Fgnoms covered this 13 years ago

“fgnoms30 Apr '11 - 10:28 - 14 of 26
0 0 0
Well here we are at the end of April and still no commercial money-making contracts have been signed. CJP at the time of the money raising reiterated break even for 2010, which would have required a few such contracts to have been signed in say late Q3 2010. So seven months on and NO such deals have been signed. I guess the important question is why? Of course we have suffered the same sorry story for the last 4 years on stroke. Yes 4 years ago contracts were imminent and apparently still are but we haven't been told why they haven't been signed. The obvious explanation is that PRM stroke biomarkers together with other panel constituents don't work well enough and therefore a stroke panel cannot be commercialised. Remember all those companies testing the PRM stroke biomarkers - and absolutely nothing has resulted. I think it would now be reasonable to assume that stroke is dead. So what about AD. Yes we are now at the same stage as stroke was 4 years ago. Tests are being carried out - but this time by PRM itself. This indicates to me that none of the big boys have any faith whatsoever in PRM's AD biomarkers - especially since the Dutch revelation that Clusterin isn't a predictive biomarker. So why does PRM continue to lead us on that a commercial deal is just around the corner. I find this bizarre. As PRM is now carrying out its own tests on its own panel nobody is going to sign anything until the results are known - which will probably be in H1 2012. And even then it really isn't feasible that a final saleable AD working panel will only contain PRM biomarkers, is it? So in my view we are years away from a working AD panel. So where does all this optimism come from - cloud cuckoo land imho.

So before my next post we will know the 2010 results - a complete disaster no doubt. A loss of nearly £5m compared with target breakeven. 2011 is also looking like another £5m loss as I don't believe any commercial contracts will be signed. 2012 may not be much better either and thats when the cash runs out. So what will the share price be when all this is revealed next month? A very far cry from anything the rampers are saying thats for sure.”

[monte1] 22/7/2024 11:23

Thanks goatherd.

[barry evans] 22/7/2024 10:51

re 92987

For the benefit of those that have the avatar goatherd filtered and will not have been able to view this (It is quite something):


wasjobber 22 Jul '24 - 10:18 - 59772 of 59774 0 1 0

I wonder how high Proteome Sciences share price will rise after Randox announce the release of their clinical Stroke test in blood?


pools2 22 Jul '24 - 10:31 - 59773 of 59774 0 0 0

wasjobber,

PRM's share price should rise significantly after Randoz release their clinical Stroke test. It could also rise before the release date.


wasjobber 22 Jul '24 - 10:43 - 59774 of 59774 0 0 0

Thanks pools2

[jeffian] 22/7/2024 10:44

As it is in the public domain and has been 'anticipated' for years, surely it is already in the price?

[wasjobber] 22/7/2024 10:43

Thanks pools2

[peverill] 22/7/2024 10:42

And why are two Avatars of the same person talking to each other over on the boring thread.No amount of ramping will move anything here,just cold hard stroke/AD news.

[pools2] 22/7/2024 10:31

wasjobber,

PRM's share price should rise significantly after Randoz release their clinical Stroke test. It could also rise before the release date.

[wasjobber] 22/7/2024 10:18

I wonder how high Proteome Sciences share price will rise after Randox announce the release of their clinical Stroke test in blood?

[monte1] 22/7/2024 10:16

Let’s hope it is to the moon, the stars and beyond.

That said it may be rather unwise to hold one’s breath on that hope or expectation.

[wasjobber] 22/7/2024 10:14

I wonder how high Proteome Sciences share price will rise after Randox announce the release of their clinical Stroke test in blood?

[sandcrab2] 21/7/2024 20:29

Nice bounce

Leak?

[monte1] 17/7/2024 17:40

More so than izal iirc from my schooldays.

[elpirata] 17/7/2024 17:31

particularly effective wrt the klingons iirc

[dominiccummings] 17/7/2024 16:34

Huh. Bones in Startrek had that tool years ago!

[colinhy] 17/7/2024 14:09

The results will be used to develop a portable analyser which runs all tests simultaneously, yielding results within 15 minutes that can then be used to guide the patient’s management.

[peverill] 17/7/2024 12:36

Stroke release has been imminent for 10 years!!

[barry evans] 17/7/2024 12:14

"STRONG BUY"

Oh aye.

[wasjobber] 17/7/2024 12:04

The clinical stroke trails ended last year and Dr Ian Pike has said Randox seem to think the stroke biochip test will be released by the end of this year.

So there is ever reason to think the new Randox stroke test release date is imminent.

STRONG BUY

[elpirata] 17/7/2024 11:35

Is 5 years & counting since 'launch' SPEED?

[dominiccummings] 15/7/2024 13:11

Old slippery, undoubtedly.

[barry evans] 15/7/2024 12:27

For clarity, could you confirm which you are referring to. elpirata, POTUS or old slippery?